• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. DIALYSIS UNKNOWN; CATHETER, PERITONEAL, LONG-TERM INDWELLING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG SOLUTIONS S.A. DIALYSIS UNKNOWN; CATHETER, PERITONEAL, LONG-TERM INDWELLING Back to Search Results
Model Number DIALYSIS UNKNOWN
Device Problem Product Quality Problem (1506)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Date 10/26/2020
Event Type  Injury  
Manufacturer Narrative
Title: prolonged intermittent renal replacement therapy for acute kidney injury in covid-19 patients with acute respiratory distress syndrome source: blood purification 2021;50:355¿363.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the literature case study, this was a single-center, prospective, observational study performed at a tertiary reference hospital designated to treat exclusively patients with covid-19 from march 16, 2020 to june24, 2020.The study identified 224 covid-19 patients admitted to the icu; 136 (60.7%) of them developed hospital-acquired aki (acute kidney injury), and among them, 39 (29%) had stage 3 aki according to kdigo (kidney disease improving global outcomes) definitions.In these patients, 21 (15%) initiated prolonged intermittent renal replacement therapy (pirrt).Intradialytic hypotensive events occurred in 56 (43%) procedures.Intradialytic hypotensive episodes were identified promptly in the majority of episodes and treated with 2 maneuvers: increasing norepinephrine dose (54/56, 96%) and reducing fluid removal rate by decreasing total ultrafiltrate (10/56, 18%) or by increasing session duration (46/56, 82%).Fifteen (12%) pirrt treatments were discontinued before reaching the ultrafiltration goal due to severe intradialytic hypotension.Other causes of pirrt discontinuation were recurrent dialysis system clotting, arrhythmia, and refractory hypoxemia in 5, 1, and 1 procedure, respectively.Two patients were switched to crrt due to severe hypotension after 2 consecutive pirrt treatments failed on subsequent days.During follow-up, 11 patients (52%) recovered from aki and respiratory failure, and 1 (5%) patient was still hospitalized at the time of writing this report, yet the patient has recovered renal function and, subsequently, pirrt has already been discontinued.
 
Manufacturer Narrative
Additional information: removal of fdp and imf code of hospitalization or prolonged hospitalization and outcome attributed to adverse event medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIALYSIS UNKNOWN
Type of Device
CATHETER, PERITONEAL, LONG-TERM INDWELLING
Manufacturer (Section D)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
CS  20101
MDR Report Key12462853
MDR Text Key271261403
Report Number3009211636-2021-00249
Device Sequence Number1
Product Code FJS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 09/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberDIALYSIS UNKNOWN
Device Catalogue NumberDIALYSIS UNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received08/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-